285 related articles for article (PubMed ID: 22138189)
1. Hepatitis C virus infects the endothelial cells of the blood-brain barrier.
Fletcher NF; Wilson GK; Murray J; Hu K; Lewis A; Reynolds GM; Stamataki Z; Meredith LW; Rowe IA; Luo G; Lopez-Ramirez MA; Baumert TF; Weksler B; Couraud PO; Kim KS; Romero IA; Jopling C; Morgello S; Balfe P; McKeating JA
Gastroenterology; 2012 Mar; 142(3):634-643.e6. PubMed ID: 22138189
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis C virus infection of neuroepithelioma cell lines.
Fletcher NF; Yang JP; Farquhar MJ; Hu K; Davis C; He Q; Dowd K; Ray SC; Krieger SE; Neyts J; Baumert TF; Balfe P; McKeating JA; Wong-Staal F
Gastroenterology; 2010 Oct; 139(4):1365-74. PubMed ID: 20538002
[TBL] [Abstract][Full Text] [Related]
3. A preliminary analysis of hepatitis C virus in pancreatic islet cells.
Blackard JT; Kong L; Lombardi A; Homann D; Hammerstad SS; Tomer Y
Virol J; 2017 Dec; 14(1):237. PubMed ID: 29258547
[TBL] [Abstract][Full Text] [Related]
4. Zika Virus Persistently Infects and Is Basolaterally Released from Primary Human Brain Microvascular Endothelial Cells.
Mladinich MC; Schwedes J; Mackow ER
mBio; 2017 Jul; 8(4):. PubMed ID: 28698279
[TBL] [Abstract][Full Text] [Related]
5. Single amino acid mutation of SR-BI decreases infectivity of hepatitis C virus derived from cell culture in a cell culture model.
Gao R; Gao W; Xu G; Xu J; Ren H
World J Gastroenterol; 2017 Jul; 23(28):5158-5166. PubMed ID: 28811710
[TBL] [Abstract][Full Text] [Related]
6. Nonstructural 3 Protein of Hepatitis C Virus Modulates the Tribbles Homolog 3/Akt Signaling Pathway for Persistent Viral Infection.
Tran SC; Pham TM; Nguyen LN; Park EM; Lim YS; Hwang SB
J Virol; 2016 Aug; 90(16):7231-7247. PubMed ID: 27252525
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.
Bocchetta S; Maillard P; Yamamoto M; Gondeau C; Douam F; Lebreton S; Lagaye S; Pol S; Helle F; Plengpanich W; Guérin M; Bourgine M; Michel ML; Lavillette D; Roingeard P; le Goff W; Budkowska A
PLoS One; 2014; 9(3):e92140. PubMed ID: 24646941
[TBL] [Abstract][Full Text] [Related]
8. Is HCV infection a neurologic disorder?
Féray C
Gastroenterology; 2012 Mar; 142(3):428-31. PubMed ID: 22285362
[No Abstract] [Full Text] [Related]
9. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
10. [Research on hepatitis C virus entry inhibitor].
Zeng Wenting ; Lu X; Wang J; Jin X; Zhu J
Bing Du Xue Bao; 2015 Jan; 31(1):97-105. PubMed ID: 25997338
[TBL] [Abstract][Full Text] [Related]
11. Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.
Haid S; Windisch MP; Bartenschlager R; Pietschmann T
J Virol; 2010 Jan; 84(2):964-75. PubMed ID: 19889758
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HCV 3a genotype entry through host CD81 and HCV E2 antibodies.
Ashfaq UA; Qasim M; Yousaf MZ; Awan MT; Jahan S
J Transl Med; 2011 Nov; 9():194. PubMed ID: 22074322
[TBL] [Abstract][Full Text] [Related]
13. Hypervariable region 1 deletion and required adaptive envelope mutations confer decreased dependency on scavenger receptor class B type I and low-density lipoprotein receptor for hepatitis C virus.
Prentoe J; Serre SB; Ramirez S; Nicosia A; Gottwein JM; Bukh J
J Virol; 2014 Feb; 88(3):1725-39. PubMed ID: 24257605
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis.
Gelley F; Zadori G; Nemes B; Fassan M; Lendvai G; Sarvary E; Doros A; Gerlei Z; Nagy P; Schaff Z; Kiss A
J Gastroenterol Hepatol; 2014 Jan; 29(1):121-7. PubMed ID: 24033414
[TBL] [Abstract][Full Text] [Related]
15. Expression profiles of genes associated with viral entry in HCV-infected human liver.
Nakamuta M; Fujino T; Yada R; Aoyagi Y; Yasutake K; Kohjima M; Fukuizumi K; Yoshimoto T; Harada N; Yada M; Kato M; Kotoh K; Taketomi A; Maehara Y; Nakashima M; Enjoji M
J Med Virol; 2011 May; 83(5):921-7. PubMed ID: 21412800
[TBL] [Abstract][Full Text] [Related]
16. Incorporation of primary patient-derived glycoproteins into authentic infectious hepatitis C virus particles.
Doerrbecker J; Friesland M; Riebesehl N; Ginkel C; Behrendt P; Brown RJ; Ciesek S; Wedemeyer H; Sarrazin C; Kaderali L; Pietschmann T; Steinmann E
Hepatology; 2014 Aug; 60(2):508-20. PubMed ID: 24771613
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.
Schvoerer E; Moenne-Loccoz R; Murray JM; Velay A; Turek M; Fofana I; Fafi-Kremer S; Erba AC; Habersetzer F; Doffoël M; Gut JP; Donlin MJ; Tavis JE; Zeisel MB; Stoll-Keller F; Baumert TF
J Infect Dis; 2013 Apr; 207(8):1306-15. PubMed ID: 23335805
[TBL] [Abstract][Full Text] [Related]
18. The level of CD81 cell surface expression is a key determinant for productive entry of hepatitis C virus into host cells.
Koutsoudakis G; Herrmann E; Kallis S; Bartenschlager R; Pietschmann T
J Virol; 2007 Jan; 81(2):588-98. PubMed ID: 17079281
[TBL] [Abstract][Full Text] [Related]
19. Deep sequencing of hepatitis C virus reveals genetic compartmentalization in cerebrospinal fluid from cognitively impaired patients.
Tully DC; Hjerrild S; Leutscher PD; Renvillard SG; Ogilvie CB; Bean DJ; Videbech P; Allen TM; McKeating JA; Fletcher NF
Liver Int; 2016 Oct; 36(10):1418-24. PubMed ID: 27045383
[TBL] [Abstract][Full Text] [Related]
20. CD36 is a co-receptor for hepatitis C virus E1 protein attachment.
Cheng JJ; Li JR; Huang MH; Ma LL; Wu ZY; Jiang CC; Li WJ; Li YH; Han YX; Li H; Chen JH; Wang YX; Song DQ; Peng ZG; Jiang JD
Sci Rep; 2016 Feb; 6():21808. PubMed ID: 26898231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
